The treatment led to primary tumor suppression (tumor volume ≈ 0 mm3) and an increase in CD8+ and CD4+ T cells, 9.3- and 10.3-fold higher compared to control groups (Figure 5A), followed by a reduction of metastasis. This evidence concerns the gene CD8A and neoplasm.